Erste Asset Management GmbH bought a new position in shares of Danaher Co. (NYSE:DHR - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 21,740 shares of the conglomerate's stock, valued at approximately $5,988,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Fort Pitt Capital Group LLC lifted its stake in shares of Danaher by 3.2% in the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate's stock valued at $66,194,000 after acquiring an additional 7,421 shares during the last quarter. Good Life Advisors LLC bought a new position in shares of Danaher in the 3rd quarter valued at $217,000. Oak Thistle LLC bought a new position in shares of Danaher in the 2nd quarter valued at $363,000. Harvest Portfolios Group Inc. lifted its stake in shares of Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate's stock valued at $56,233,000 after acquiring an additional 2,465 shares during the last quarter. Finally, Diversified Trust Co lifted its stake in shares of Danaher by 75.4% in the 2nd quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate's stock valued at $1,090,000 after acquiring an additional 1,874 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
DHR has been the subject of a number of recent research reports. TD Cowen increased their price objective on Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. StockNews.com upgraded Danaher from a "hold" rating to a "buy" rating in a report on Wednesday, November 27th. UBS Group decreased their price objective on Danaher from $309.00 to $305.00 and set a "buy" rating for the company in a report on Wednesday, October 23rd. Wells Fargo & Company initiated coverage on Danaher in a report on Tuesday, August 27th. They issued an "equal weight" rating and a $280.00 price objective for the company. Finally, KeyCorp increased their price objective on Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a report on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $287.16.
Check Out Our Latest Stock Analysis on DHR
Danaher Stock Performance
Shares of Danaher stock traded down $0.43 during mid-day trading on Tuesday, hitting $240.86. 3,035,260 shares of the stock were exchanged, compared to its average volume of 2,750,274. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a market capitalization of $173.97 billion, a P/E ratio of 45.97, a P/E/G ratio of 4.44 and a beta of 0.83. The company has a 50-day simple moving average of $253.28 and a 200 day simple moving average of $259.07. Danaher Co. has a 12 month low of $215.68 and a 12 month high of $281.70.
Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher's revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.02 EPS. Sell-side analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher's dividend payout ratio (DPR) is presently 20.61%.
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
